GE HealthCare Technologies (NASDAQ:GEHC) Releases FY 2025 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.610-4.750 for the period, compared to the consensus estimate of 4.650. The company issued revenue guidance of -.

GE HealthCare Technologies Price Performance

GEHC traded down $1.91 during midday trading on Friday, reaching $91.57. 884,656 shares of the company’s stock were exchanged, compared to its average volume of 2,756,302. GE HealthCare Technologies has a one year low of $74.51 and a one year high of $94.80. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The business has a 50-day simple moving average of $83.81 and a two-hundred day simple moving average of $85.44. The firm has a market capitalization of $41.84 billion, a price-to-earnings ratio of 25.18, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. As a group, research analysts predict that GE HealthCare Technologies will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.85%.

Analyst Ratings Changes

A number of research firms have recently issued reports on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $97.31.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.